AWMSG recommendations on the use of plerixafor

AWMSG has recommended the use of plerixafor (MozobilĀ®) as an option within NHS Wales in combination with granulocyte-colony stimulating factor (G-CSF) to enhance mobilisation of haematopoietic stem cells in myeloma patients whose cells mobilise poorly. Patients may use plerixafor if they have already failed one complete mobilisation attempt.